Veritas Collaborative AI Visibility Market Strategy Report - Eating Disorder Treatment Centers

Answer Capsule

Veritas Collaborative recorded no presence and no valid recommendations across every tracked month from July 2026 through October 2026 in the LLM Authority Index Eating Disorder Treatment Centers benchmark. The brand appeared in 0.00% of the 65 qualified October 2026 observations, received 0 valid recommendations, and held a 0.00% top-three rate and 0.00% rank-one rate. Every other tracked treatment center in the category registered at least some presence, and eight of the nine recorded at least one valid recommendation. The clearest opportunity is foundational: establishing any retrievable public evidence layer that AI systems can surface when prospective patients ask for eating disorder treatment recommendations.

Who This Report Is For

This report is for Veritas Collaborative's marketing, admissions, and executive leadership teams, and for anyone responsible for the brand's visibility in AI-generated treatment recommendations.

Report Card

Executive Summary

Veritas Collaborative is the only tracked brand in the October 2026 Eating Disorder Treatment Centers benchmark with zero presence and zero valid recommendations across the full July-to-October series. The brand was not mentioned in any of the 65 qualified October 2026 observations, received no valid recommendation credit, and recorded a 0.00% raw mention presence rate, a 0.00% valid recommendation coverage rate, a 0.00% top-three rate, and a 0.00% rank-one rate. Its net sentiment score is 0.0, reflecting the absence of any classified mentions rather than a balanced mix of positive and negative framing.

The contrast with the rest of the category is stark. The Emily Program leads October 2026 at 18.5% valid recommendation coverage, Monte Nido follows at 13.9%, and Alsana holds 12.3%. Even Walden Behavioral Care, the next-lowest brand after Veritas Collaborative, recorded 4.6% valid recommendation coverage, a 6.2% raw mention presence rate, and 3 valid recommendations in the 65 qualified observations. Veritas Collaborative recorded none of these.

The benchmark's qualified observation set is small, at 65 observations in October 2026, so brand-level percentages rest on limited absolute counts. That limitation does not explain a zero reading across four consecutive monthly measurements. The pattern is consistent with a brand that is absent from the prompt universe the benchmark samples, or absent from the public evidence layer that AI systems retrieve when forming treatment center recommendations.

The category itself is moving. The valid recommendation shortlist share climbed from 6.6% in July 2026 to 29.2% in October 2026, meaning AI systems produced actionable recommendations in a growing share of qualified observations. Three brands, Center for Discovery, Monte Nido, and Rogers Behavioral Health, recorded coverage gains the benchmark classifies as significant against the July baseline. Veritas Collaborative did not participate in any of that movement.

The strongest signal in the data is not a weakness in framing or placement. It is total absence. Veritas Collaborative has no mentions to classify, no recommendations to rank, and no sentiment to score. The clearest opportunity is to establish a baseline presence in the prompt and source layers that AI systems draw from, then convert that presence into valid recommendation credit.

What Veritas Collaborative Is Winning

The uploaded data does not support any evidence-backed wins for Veritas Collaborative in the October 2026 benchmark. The brand recorded 0 mentions, 0 valid recommendations, 0 top-three placements, 0 rank-one placements, and a 0.00% presence rate across all 65 qualified observations. Its average recommended rank is not applicable because it received no rank-eligible recommendations.

This is stated plainly rather than softened. A zero reading across every measured dimension is a different situation from a brand with weak but nonzero performance, and the report treats it as such.

Where Veritas Collaborative Has the Clearest AI Visibility Gaps

Questions This Section Answers

• How does Veritas Collaborative's absence differ from competitors who are mentioned but not recommended?
• Where in the source layer are other eating disorder treatment centers appearing that Veritas Collaborative is not?
• Why does Veritas Collaborative's absence concentrate in the Brand Recommendation cluster?

Veritas Collaborative's clearest gap is total absence from the qualified observation set. The brand was not surfaced in any of the 65 October 2026 qualified observations, and it recorded no presence in July, August, or September 2026 either. This is not a case of being mentioned but not recommended, which is the pattern Monte Nido shows at 58.5% presence against 13.9% recommendation coverage. It is a case of not appearing at all.

The gap is visible against every competitor. Walden Behavioral Care, the nearest brand by coverage, recorded a 6.2% raw mention presence rate and 3 valid recommendations in October 2026, with an average recommended rank of 7.33 and no top-three placements. Even that limited profile represents presence and recommendation credit that Veritas Collaborative did not receive. The gap between Monte Nido, the category's highest-presence brand at 58.5%, and Veritas Collaborative widened by 11.7 points from July 2026 to October 2026.

The benchmark's prompt universe is concentrated in a single buyer-intent cluster. All 65 qualified October 2026 observations fell into the Brand Recommendation cluster, covering prompts where AI systems recommend one or more named treatment centers. The Pricing & Value and Multi-Brand Comparison clusters produced no qualified observations in any tracked month. Veritas Collaborative's absence therefore sits specifically in the cluster where AI systems are actively steering prospective patients toward named providers.

The source layer shows a related pattern. Across all AI platform responses in the measurement period, 2,212 citations were observed across 602 unique domains. Four tracked brands have their own domains in the top 10 cited sources: Rogers Behavioral Health (rogersbh.org) at 118 citations, Monte Nido (montenido.com) at 110, The Emily Program (emilyprogram.com) at 95, and The Renfrew Center (renfrewcenter.com) at 43. Veritas Collaborative does not appear in the top 10 cited domains. The benchmark notes that source presence is evidence about the information environment and is not automatically proof that a source caused a recommendation, but the absence of a brand's own domain from the cited source layer is consistent with the absence of the brand from the recommendation layer.

Biggest Opportunity

Questions This Section Answers

• What is the first step for Veritas Collaborative to become recommendable in AI-generated treatment center shortlists?
• Which treatment-discovery questions do AI systems already field that Veritas Collaborative could answer?

The single biggest opportunity for Veritas Collaborative is to establish a retrievable public evidence layer that AI systems can surface in the Brand Recommendation cluster, where all qualified category observations currently sit. The benchmark's prompt examples for this cluster include condition and treatment-discovery queries such as "arfid diagnosis," "bulimia," "binge eating disorder," "eating disorder test," "iop program," and "types of eating disorders." These are the questions prospective patients and their families ask before they ever contact a treatment center, and they are the questions where AI systems are currently recommending other brands.

Because Veritas Collaborative has no presence to correct, the path from reference to recommendation starts with becoming referenceable. That means building owned and third-party source content that AI systems can retrieve, cite, and synthesize when forming treatment center recommendations, then tracking whether that content converts into mentions and, eventually, into valid recommendation credit. The benchmark's own framing applies directly here: the public benchmark identifies where attention is warranted, and a company-level analysis is needed to explain why.

Competitive Landscape

Questions This Section Answers

• Which eating disorder treatment center leads on recommendation-stage visibility in October 2026?
• How does Veritas Collaborative compare with the lowest-ranked competitor still receiving recommendation credit?

The Emily Program holds the strongest recommendation-stage position in the October 2026 Eating Disorder Treatment Centers benchmark, with Monte Nido and Alsana close behind on coverage. Veritas Collaborative sits at the bottom of the tracked set with no recommendation-stage presence at all.

Average recommended rank covers rank-eligible recommendations only.

Veritas Collaborative is the only tracked brand with a 0.00% top-three rate, a 0.00% rank-one rate, and no rank-eligible recommendations. Walden Behavioral Care, the next-lowest brand, still recorded a 4.62% valid recommendation coverage rate and an average recommended rank of 7.33, meaning it received recommendation credit even though none of its placements reached the top three. The table shows Veritas Collaborative outside the recommendation distribution entirely rather than at the bottom of it.

Prompt Evidence

[AI Mode] / Brand Recommendation Prompt: "iop program" Result: Veritas Collaborative was not surfaced in any qualified October 2026 observation for this cluster, while competitors including Monte Nido and The Emily Program received recommendation credit.

[AI Overviews] / Brand Recommendation Prompt: "types of eating disorders" Result: The Emily Program and Rogers Behavioral Health recorded positive recommendation placements on this surface, while Veritas Collaborative recorded no presence.

[AI Mode] / Brand Recommendation Prompt: "eating disorder test" Result: The prompt appeared in the cluster's example set across multiple brand packets, and Veritas Collaborative did not appear in any qualified response.

[AI Mode] / Brand Recommendation Prompt: "arfid diagnosis" Result: This condition-discovery prompt appeared across the cluster's example set, and Veritas Collaborative received no mention or recommendation credit in the qualified October 2026 observations.

What CiteWorks Studio Would Do Next

Questions This Section Answers

• What does the phased plan recommend for building an owned answer layer and citation footprint?
• Which metrics should Veritas Collaborative track monthly to measure progress from absence to recommendation credit?

Phase 1: AI Visibility Market Discovery Audit Map the exact prompt, surface, competitor, and source patterns where Veritas Collaborative is absent, and confirm whether the brand appears anywhere in the broader collection universe beyond the qualified benchmark set.

Phase 2: Recommendation Readiness Plan Define which high-intent Brand Recommendation prompts the brand should be eligible for, and set a baseline target for first mention and first valid recommendation.

Phase 3: Owned Answer Layer Buildout Build owned content that directly answers the condition, program, and treatment-discovery questions AI systems are already fielding in this category.

Phase 4: Citation / Authority Layer Development Develop the third-party and clinical source footprint that AI systems retrieve and cite, since four tracked competitors already hold domains in the top 10 cited sources and Veritas Collaborative does not.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track presence, valid recommendation coverage, top-three rate, rank-one rate, and sentiment month over month against the benchmark's qualified observation set.

Why This Matters

Questions This Section Answers

• What share of AI observations now produce a valid eating disorder treatment recommendation shortlist?
• Why is a zero presence reading harder for Veritas Collaborative to overcome than a low recommendation rate?

AI systems are now forming treatment center shortlists before a prospective patient or family member ever visits a website or makes a call. In the October 2026 benchmark, 29.2% of qualified observations produced a valid recommendation shortlist, up from 6.6% in July 2026. That means AI systems are naming specific eating disorder treatment centers in a growing share of the questions people ask. A brand that does not appear in those answers is not part of the shortlist, regardless of its clinical quality or reputation.

Presence alone is not enough, as Monte Nido's 58.5% presence against 13.9% recommendation coverage shows. But absence is a harder starting point than weak conversion. For Veritas Collaborative, the next move is not to improve framing or climb from a lower rank. It is to become retrievable, citable, and recommendable in the first place, by correcting the prompt, page, and citation layers that currently produce no signal at all.

Core Metrics

Sentiment Score

Questions This Section Answers

• Why does a zero sentiment score for Veritas Collaborative mean something different from a neutral sentiment score?
• Why is a zero-mention sentiment reading impossible to interpret without classified mentions?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Veritas Collaborative, the score is 0.0 because the brand recorded 0 positive mentions, 0 neutral mentions, and 0 negative mentions across 65 qualified October 2026 observations. This is not a neutral framing result. It is the absence of any framing at all.

This distinction matters because unclassified mention counts are misleading. A brand with 10 mentions split evenly between positive and negative framing and a brand with zero mentions both produce a score near zero, but they face completely different problems. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal, and counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, and for Veritas Collaborative there is nothing yet to classify.

Sentiment by Platform

Methodology

1. This report is a benchmark-based AI market strategy analysis of Veritas Collaborative within the Eating Disorder Treatment Centers category, produced from the LLM Authority Index October 2026 measurement and supporting metrics aggregation.
2. The reporting month is October 2026, with comparison points from July 2026, August 2026, and September 2026.
3. Three qualified AI surface families contributed observations in October 2026: Copilot, AI Mode, and AI Overviews. The benchmark tracks six canonical surface families overall, and the third qualified surface changed from Gemini in August and September 2026 to Copilot in October 2026.
4. The October 2026 measurement began with 320 source prompt-surface observations covering 246 unique questions. Of those, 220 were relevant to the category and 100 were irrelevant, producing 65 qualified benchmark observations after qualification.
5. The competitor universe contains nine tracked brands: Alsana, Center for Discovery, ERC Pathlight, Monte Nido, Rogers Behavioral Health, The Emily Program, The Renfrew Center, Veritas Collaborative, and Walden Behavioral Care.
6. All 65 qualified October 2026 observations fell into the Brand Recommendation buyer-intent cluster. The Pricing & Value and Multi-Brand Comparison clusters produced no qualified observations in any tracked month.
7. Stage 0 extraction retains the query, AI or search surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources for each prompt-level observation.
8. A mention is counted when a tracked brand appears in a qualified observation, regardless of whether it is recommended.
9. A valid recommendation is counted when the dataset explicitly marks a brand as recommended, with rank-eligible recommendations receiving placement credit. Negative, neutral, cautionary, comparison-anchor, and listed-only mentions are not counted as valid recommendations.
10. Brand-level percentages use the 65 qualified observations as the public denominator, not the raw collection of 320 prompt-surface observations.
11. The qualified observation count fell from 91 in July 2026 to 65 in October 2026, so brand-level percentages rest on small absolute counts and single-prompt shifts can move percentages by several points.
12. Source presence is evidence about the information environment and is not automatically proof that a source caused a recommendation. The benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, private or sponsored channels, or causality from a metric movement alone.

Find Out Where You Stand in AI Recommendations

The public benchmark shows category-level standings across the Eating Disorder Treatment Centers market. A company-level Authority Index goes deeper, mapping the specific prompts, surfaces, competitors, and source patterns that determine whether a brand appears in AI-generated treatment recommendations at all. For a brand currently outside the recommendation distribution, that mapping is the starting point.